Request Demo
Recent blog posts
Latest Hotspot
8 min read
Pancreaticopleural fistula Indication Strategy Report 2026: Somatostatin receptor, Trials and Deals
3 August 2026
2026 Pancreaticopleural fistula indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Pancreatic ascites Indication Strategy Report 2026: Somatostatin receptor, Trials and Deals
3 August 2026
2026 Pancreatic ascites indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Tropical chronic pancreatitis Indication Strategy Report 2026: CFTR, Trials and Deals
3 August 2026
2026 Tropical chronic pancreatitis indication strategy covering epidemiology, CFTR biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pancreatic exocrine insufficiency Indication Strategy Report 2026: CFTR, Trials and Deals
3 August 2026
2026 Pancreatic exocrine insufficiency indication strategy covering epidemiology, CFTR biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Recurrent acute pancreatitis Indication Strategy Report 2026: TRPV1, Trials and Deals
3 August 2026
2026 Recurrent acute pancreatitis indication strategy covering epidemiology, TRPV1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Hereditary pancreatitis Indication Strategy Report 2026: PRSS1, Trials and Deals
3 August 2026
2026 Hereditary pancreatitis indication strategy covering epidemiology, PRSS1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Mesenteric panniculitis Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Mesenteric panniculitis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Autoimmune pancreatitis type 1 Indication Strategy Report 2026: CD20, Trials and Deals
3 August 2026
2026 Autoimmune pancreatitis type 1 indication strategy covering epidemiology, CD20 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Median arcuate ligament syndrome Indication Strategy Report 2026: CGRP, Trials and Deals
3 August 2026
2026 Median arcuate ligament syndrome indication strategy covering epidemiology, CGRP biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Rumination syndrome Indication Strategy Report 2026: 5-HT4, Trials and Deals
3 August 2026
2026 Rumination syndrome indication strategy covering epidemiology, 5-HT4 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Superior mesenteric artery syndrome Indication Strategy Report 2026: GHRL, Trials and Deals
3 August 2026
2026 Superior mesenteric artery syndrome indication strategy covering epidemiology, GHRL biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Abdominal migraine Indication Strategy Report 2026: CGRP, Trials and Deals
3 August 2026
2026 Abdominal migraine indication strategy covering epidemiology, CGRP biology, active trials, transactions, unmet need, competition and market attractiveness.